Go Pro
→ Trump’s New Currency Reset (From Porter & Company) (Ad)tc pixel Free INTT Stock Alerts

inTEST (INTT) Financials

inTEST logo
$13.59 -0.33 (-2.37%)
Closing price 08/13/2026 04:00 PM Eastern
Extended Trading
$13.62 +0.04 (+0.26%)
As of 07:01 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for inTEST

Annual Income Statements for inTEST

This table shows inTEST's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 1.86 2.66 0.98 3.04 2.32 -0.90 7.28 8.46 9.34 2.89 -2.53
Consolidated Net Income / (Loss)		 1.86 2.66 0.98 3.04 2.32 -0.90 7.28 8.46 9.34 2.89 -2.53
Net Income / (Loss) Continuing Operations		 1.86 2.66 0.98 3.04 2.32 -0.90 7.28 8.46 9.34 2.89 -2.53
Total Pre-Tax Income 		2.58 4.21 3.84 5.04 2.60 -1.23 8.40 10 11 3.45 -3.22
Total Operating Income		 2.56 4.15 3.61 5.18 2.55 -1.22 8.46 11 10 3.39 -3.73
Total Gross Profit		 19 20 35 39 29 24 41 53 57 55 49
Total Revenue		 39 40 67 79 61 54 85 117 123 131 114
Operating Revenue		 39 40 67 79 61 54 85 117 123 131 114
Total Cost of Revenue		 20 20 32 39 31 30 44 63 66 75 65
Operating Cost of Revenue		 20 20 32 39 31 30 44 63 66 75 65
Total Operating Expenses		 16 16 31 34 27 25 33 43 47 52 53
Selling, General & Admin Expense		 12 13 20 22 21 19 27 35 39 41 39
Research & Development Expense		 3.94 3.66 4.30 4.91 4.96 5.07 5.53 7.53 7.62 8.55 9.44
Amortization Expense		 - - - - - - - - - 2.55 3.35
Restructuring Charge		 - - - - 0.24 1.29 - - - 0.00 0.85
Total Other Income / (Expense), net		 0.02 0.06 0.23 -0.14 0.06 -0.01 -0.06 -0.58 0.61 0.06 0.50
Interest Expense		 - - - - - - 0.09 0.64 0.68 0.85 0.45
Other Income / (Expense), net		 0.02 0.06 0.23 -0.14 0.06 -0.01 0.03 0.06 1.29 0.91 0.95
Income Tax Expense		 0.72 1.55 2.86 2.01 0.28 -0.34 1.12 1.68 1.71 0.56 -0.70
Basic Earnings per Share		 $0.18 $0.26 $0.09 $0.29 $0.22 ($0.09) $0.70 $0.79 $0.82 $0.24 ($0.21)
Weighted Average Basic Shares Outstanding		 10.47M 10.31M 10.28M 10.35M 10.37M 10.26M 10.46M 10.67M 11.46M 12.15M 12.20M
Diluted Earnings per Share		 $0.18 $0.26 $0.09 $0.29 $0.22 ($0.09) $0.68 $0.78 $0.79 $0.24 ($0.21)
Weighted Average Diluted Shares Outstanding		 10.49M 10.33M 10.34M 10.38M 10.39M 10.26M 10.73M 10.86M 11.78M 12.24M 12.20M
Weighted Average Basic & Diluted Shares Outstanding		 10.50M 10.40M 10.47M 10.57M 10.43M 10.70M 10.96M 11.12M 12.16M 12.37M 12.50M

Quarterly Income Statements for inTEST

This table shows inTEST's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders		 1.46 0.66 0.23 0.50 1.50 -2.33 -0.50 -0.94 1.24 0.79 0.47
Consolidated Net Income / (Loss)		 1.46 0.66 0.23 0.50 1.50 -2.33 -0.50 -0.94 1.24 0.79 0.47
Net Income / (Loss) Continuing Operations		 1.46 0.66 0.23 0.50 1.50 -2.33 -0.50 -0.94 1.24 0.79 0.47
Total Pre-Tax Income 		1.57 0.79 0.30 0.57 1.80 -2.79 -0.58 -1.23 1.38 0.98 0.25
Total Operating Income		 1.11 0.49 0.34 0.49 2.08 -2.88 -0.93 -1.19 1.28 0.95 0.36
Total Gross Profit		 12 13 14 14 15 11 12 11 15 15 14
Total Revenue		 28 30 34 30 37 27 28 26 33 34 35
Operating Revenue		 28 30 34 30 37 27 28 26 33 34 35
Total Cost of Revenue		 15 17 20 16 22 16 16 15 18 18 21
Operating Cost of Revenue		 15 17 20 16 22 16 16 15 18 18 21
Total Operating Expenses		 11 13 13 14 12 14 13 12 14 14 14
Selling, General & Admin Expense		 9.41 10 10 10 10 10 9.59 8.89 10 10 11
Research & Development Expense		 1.93 1.98 2.22 2.18 2.17 2.45 2.25 2.34 2.41 2.59 2.50
Amortization Expense		 - 0.60 0.90 0.94 - 0.81 0.85 0.84 0.84 0.78 0.70
Restructuring Charge		 - 0.00 0.00 0.00 - 0.31 0.22 0.12 0.21 0.74 0.03
Total Other Income / (Expense), net		 0.46 0.30 -0.04 0.08 -0.28 0.09 0.34 -0.03 0.10 0.02 -0.11
Interest Expense		 0.15 0.14 0.25 0.22 0.23 0.15 0.12 0.10 0.08 0.08 0.06
Other Income / (Expense), net		 0.61 0.44 0.21 0.30 -0.04 0.24 0.46 0.06 0.19 0.10 -0.05
Income Tax Expense		 0.11 0.13 0.07 0.07 0.30 -0.46 -0.08 -0.29 0.13 0.19 -0.23
Basic Earnings per Share		 $0.12 $0.06 $0.02 $0.04 $0.12 ($0.19) ($0.04) ($0.08) $0.10 $0.06 $0.04
Weighted Average Basic Shares Outstanding		 11.46M 12.03M 12.23M 12.19M 12.15M 12.18M 12.22M 12.21M 12.20M 12.25M 12.31M
Diluted Earnings per Share		 $0.11 $0.05 $0.02 $0.04 $0.13 ($0.19) ($0.04) ($0.08) $0.10 $0.06 $0.04
Weighted Average Diluted Shares Outstanding		 11.78M 12.16M 12.33M 12.25M 12.24M 12.18M 12.22M 12.21M 12.20M 12.42M 12.58M
Weighted Average Basic & Diluted Shares Outstanding		 12.16M 12.49M 12.52M 12.37M 12.37M 12.49M 12.48M 12.48M 12.50M 12.56M 12.83M

Annual Cash Flow Statements for inTEST

This table details how cash moves in and out of inTEST's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 2.58 2.90 -15 4.57 -10 2.67 11 -6.62 31 -25 -1.77
Net Cash From Operating Activities		 3.50 4.29 7.24 11 -8.41 3.25 11 -1.39 16 3.82 7.32
Net Cash From Continuing Operating Activities		 3.50 4.29 7.24 11 -8.41 3.25 11 -1.39 16 3.82 7.32
Net Income / (Loss) Continuing Operations		 1.86 2.66 0.98 3.04 2.32 -0.90 7.28 8.46 9.34 2.89 -2.53
Consolidated Net Income / (Loss)		 1.86 2.66 0.98 3.04 2.32 -0.90 7.28 8.46 9.34 2.89 -2.53
Depreciation Expense		 0.75 0.60 1.78 1.87 3.19 3.17 3.15 4.73 4.68 5.39 6.80
Non-Cash Adjustments To Reconcile Net Income		 0.72 0.64 5.96 12 -11 0.56 0.71 1.41 1.08 1.21 0.01
Changes in Operating Assets and Liabilities, net		 0.16 0.39 -1.47 -6.43 -3.29 0.41 -0.30 -16 1.10 -5.67 3.04
Net Cash From Investing Activities		 -0.60 -0.34 -23 -6.34 -0.62 -0.65 -21 -1.17 -1.29 -20 -1.63
Net Cash From Continuing Investing Activities		 -0.60 -0.34 -23 -6.34 -0.62 -0.65 -21 -1.17 -1.29 -20 -1.63
Purchase of Property, Plant & Equipment		 -0.60 -0.34 -0.75 -2.21 -0.62 -0.66 -0.99 -1.37 -1.29 -1.32 -1.63
Acquisitions		 - 0.00 -22 -4.12 - 0.00 -20 -0.18 0.00 -19 0.00
Net Cash From Financing Activities		 -0.16 -0.98 -0.06 0.00 -1.14 -0.07 22 -3.73 16 -8.64 -8.23
Net Cash From Continuing Financing Activities		 -0.16 -0.98 -0.06 0.00 -1.14 -0.07 22 -3.73 16 -8.64 -8.23
Repayment of Debt		 - - - - 0.00 -5.63 -0.40 -3.96 -4.10 -7.84 -8.35
Repurchase of Common Equity		 -0.16 -0.98 -0.06 0.00 -1.14 -0.07 - - 0.00 -1.04 0.00
Other Financing Activities, net		 - - - - - - 1.63 0.23 0.47 0.24 0.13
Other Net Changes in Cash		 - - - - -0.08 0.14 -0.28 -0.32 0.16 -0.56 0.77
Cash Interest Paid		 - - - - - - - - 0.69 0.88 0.46
Cash Income Taxes Paid		 0.79 0.64 3.47 2.86 0.54 0.05 1.32 3.92 3.24 3.07 0.19

Quarterly Cash Flow Statements for inTEST

This table details how cash moves in and out of inTEST's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents		 3.58 -18 -6.96 -2.40 1.86 2.22 -3.66 2.71 -3.04 -2.37 6.42
Net Cash From Operating Activities		 4.68 2.08 -5.09 4.25 2.59 5.54 -0.69 3.49 -1.02 -3.32 6.32
Net Cash From Continuing Operating Activities		 4.68 2.08 -5.06 4.22 2.59 5.54 -0.69 3.49 -1.02 -3.32 6.32
Net Income / (Loss) Continuing Operations		 1.46 0.66 0.23 0.50 1.50 -2.33 -0.50 -0.94 1.24 0.79 -0.13
Consolidated Net Income / (Loss)		 1.46 0.66 0.23 0.50 1.50 -2.33 -0.50 -0.94 1.24 0.79 -0.13
Depreciation Expense		 1.17 1.28 1.52 1.66 0.92 1.74 1.57 1.70 1.79 1.64 1.62
Non-Cash Adjustments To Reconcile Net Income		 0.14 0.08 1.49 0.51 0.43 -0.09 -0.10 0.05 0.15 0.69 -0.18
Changes in Operating Assets and Liabilities, net		 1.92 0.05 -8.31 1.56 -0.27 6.21 -1.65 2.68 -4.20 -6.44 5.01
Net Cash From Investing Activities		 -0.31 -19 -0.14 -0.51 -0.16 -0.23 -0.46 -0.41 -0.53 -0.64 -0.41
Net Cash From Continuing Investing Activities		 -0.31 -19 -0.14 -0.51 -0.16 -0.23 -0.46 -0.41 -0.53 -0.64 -0.41
Purchase of Property, Plant & Equipment		 -0.31 -0.34 -0.32 -0.51 -0.16 -0.23 -0.46 -0.41 -0.53 -0.64 -0.41
Net Cash From Financing Activities		 -0.97 -0.87 -0.98 -6.31 -0.48 -3.41 -2.20 -1.23 -1.39 1.67 0.62
Net Cash From Continuing Financing Activities		 -0.97 -0.87 -1.06 -6.22 -0.48 -3.44 -2.20 -1.23 -1.39 1.67 0.62
Repayment of Debt		 -1.03 -1.18 -1.95 -4.20 -0.51 -1.03 -2.21 -1.26 -1.43 1.16 -2.27
Other Financing Activities, net		 0.06 0.03 0.04 0.14 0.03 0.01 0.02 0.03 0.04 0.50 2.89
Cash Interest Paid		 - 0.15 0.26 0.23 - 0.14 0.12 0.10 0.09 0.09 0.07
Cash Income Taxes Paid		 0.25 0.10 1.05 -0.01 1.93 0.03 0.11 -0.05 0.10 -0.57 0.02

Annual Balance Sheets for inTEST

This table presents inTEST's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 40 43 62 67 60 62 104 110 135 152 151
Total Current Assets		 34 38 31 36 25 27 52 60 86 79 79
Cash & Equivalents		 26 29 13 18 7.61 10 21 13 45 20 14
Restricted Cash		 - - - - - - 0.00 1.14 - 0.00 3.84
Accounts Receivable		 4.40 5.38 12 11 9.30 8.44 17 21 18 29 26
Inventories, net		 3.52 3.68 4.97 6.52 7.18 7.48 13 23 20 27 32
Prepaid Expenses		 0.64 0.34 0.58 0.68 0.81 0.78 1.48 1.70 2.25 2.65 3.11
Plant, Property, & Equipment, net		 1.11 0.94 1.54 2.72 2.42 2.35 2.69 3.13 3.19 4.46 4.78
Total Noncurrent Assets		 4.61 3.89 30 29 32 33 49 47 46 69 68
Goodwill		 1.71 1.71 14 14 14 14 21 22 22 31 32
Intangible Assets		 1.10 0.88 16 15 14 12 22 19 17 26 25
Noncurrent Deferred & Refundable Income Taxes		 1.25 1.11 - - - - 0.00 0.28 1.44 0.07 0.78
Other Noncurrent Operating Assets		 0.20 0.03 0.03 0.03 4.87 6.42 5.96 6.34 6.00 12 9.89
Total Liabilities & Shareholders' Equity		 40 43 62 67 60 62 104 110 135 152 151
Total Liabilities		 4.06 5.06 23 24 15 17 49 45 39 52 48
Total Current Liabilities		 4.06 5.06 14 21 8.36 8.86 25 27 24 32 36
Short-Term Debt		 - 0.00 5.36 12 - 0.00 4.10 4.10 4.10 7.49 6.06
Accounts Payable		 0.91 1.37 2.03 1.79 1.98 2.42 4.28 7.39 5.52 17 21
Current Deferred Revenue		 - 0.07 0.89 1.26 0.46 0.40 6.04 4.50 3.80 4.99 6.39
Current Deferred & Payable Income Tax Liabilities		 0.03 0.58 1.20 0.70 0.87 0.83 2.02 1.41 1.04 - 0.00
Other Current Liabilities		 0.34 0.17 2.17 1.11 1.80 2.02 2.64 3.21 3.40 1.99 2.10
Total Noncurrent Liabilities		 0.00 0.00 8.79 2.89 6.52 8.42 24 18 14 21 12
Long-Term Debt		 - - - - - 0.00 16 12 7.94 7.54 1.41
Capital Lease Obligations		 - - - - 3.79 6.05 5.25 4.71 3.50 9.02 7.40
Noncurrent Deferred Revenue		 - 0.00 0.44 - - - - 0.00 1.33 1.43 1.06
Other Noncurrent Operating Liabilities		 - 0.00 5.74 0.20 0.46 0.45 1.38 1.49 1.48 2.56 2.07
Commitments & Contingencies		 - 0.00 0.00 0.00 - 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 36 38 39 43 45 45 55 65 96 100 104
Total Preferred & Common Equity		 36 38 39 43 45 45 55 65 96 100 104
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 36 38 39 43 45 45 55 65 96 100 104
Common Stock		 26 26 26 27 26 27 30 32 55 58 60
Retained Earnings		 9.01 12 13 16 18 17 24 33 42 45 43
Accumulated Other Comprehensive Income / (Loss)		 0.73 0.64 0.88 0.78 0.67 0.89 0.59 0.22 0.41 -2.14 2.46
Other Equity Adjustments		 0.00 - - - 0.00 - - -0.21 - -0.94 -0.96

Quarterly Balance Sheets for inTEST

This table presents inTEST's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets		 135 160 161 158 148 150 148 151 149
Total Current Assets		 87 85 81 81 75 75 75 80 80
Cash & Equivalents		 42 27 20 18 22 19 16 13 22
Restricted Cash		 0.00 - - - - - 4.87 2.82 0.00
Accounts Receivable		 21 23 30 28 21 23 21 30 27
Inventories, net		 22 31 29 32 28 28 28 30 28
Prepaid Expenses		 2.01 3.87 2.38 3.21 4.09 4.64 5.10 3.34 3.01
Plant, Property, & Equipment, net		 3.14 4.77 4.53 4.57 4.43 4.68 4.72 4.97 4.91
Total Noncurrent Assets		 46 69 75 73 69 70 68 66 64
Goodwill		 22 33 35 32 31 32 32 32 32
Intangible Assets		 17 29 27 28 26 27 26 24 23
Noncurrent Deferred & Refundable Income Taxes		 1.38 0.00 0.00 0.00 0.00 0.00 0.00 0.93 0.75
Other Noncurrent Operating Assets		 5.70 7.17 13 12 11 11 10 9.25 8.60
Total Liabilities & Shareholders' Equity		 135 160 161 158 148 150 148 151 149
Total Liabilities		 41 60 61 58 49 47 46 46 41
Total Current Liabilities		 27 40 36 36 31 31 32 36 32
Short-Term Debt		 4.10 9.63 12 8.27 6.88 6.43 6.53 7.42 5.35
Accounts Payable		 7.30 11 8.28 9.21 17 17 17 19 19
Current Deferred Revenue		 4.40 5.60 5.49 6.98 4.94 5.60 6.56 6.79 5.46
Current Deferred & Payable Income Tax Liabilities		 1.12 0.51 0.00 0.00 - - - 0.73 0.04
Other Current Liabilities		 3.29 4.04 3.80 3.99 2.06 2.10 2.06 2.12 2.14
Total Noncurrent Liabilities		 15 21 25 22 17 16 14 10 9.28
Long-Term Debt		 8.97 11 9.11 7.82 4.95 3.67 2.34 1.12 0.90
Capital Lease Obligations		 3.50 4.64 10 9.65 8.60 8.32 7.90 6.86 6.41
Noncurrent Deferred Revenue		 1.03 1.21 1.26 1.21 1.41 1.37 1.11 0.82 0.42
Other Noncurrent Operating Liabilities		 1.40 2.77 2.58 2.61 2.09 2.23 2.18 1.66 1.56
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 94 99 100 100 99 103 102 104 108
Total Preferred & Common Equity		 94 99 100 100 99 103 102 104 108
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 94 99 100 100 99 103 102 104 108
Common Stock		 54 57 58 57 58 59 59 60 64
Retained Earnings		 41 43 43 44 43 42 41 43 43
Accumulated Other Comprehensive Income / (Loss)		 0.00 0.31 -0.43 0.39 -0.68 2.57 2.39 1.72 1.35
Other Equity Adjustments		 -0.90 -0.93 -0.94 -0.94 -0.95 -0.96 -0.96 -1.00 -1.02

Annual Metrics And Ratios for inTEST

This table displays calculated financial ratios and metrics derived from inTEST's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 10,562,678.00 10,376,770.00 10,413,058.00 10,489,958.00 10,494,761.00 10,529,123.00 10,873,392.00 11,022,949.00 24,326,010.00 - 12,483,433.00
DEI Adjusted Shares Outstanding		 10,562,678.00 10,376,770.00 10,413,058.00 10,489,958.00 10,494,761.00 10,529,123.00 10,873,392.00 11,022,949.00 24,326,010.00 - 12,483,433.00
DEI Earnings Per Adjusted Shares Outstanding		 0.18 0.26 0.09 0.29 0.22 -0.09 0.67 0.77 0.38 - -0.20
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -6.96% 3.44% 66.06% 17.61% -22.79% -11.27% 57.70% 37.64% 5.54% 5.99% -12.90%
EBITDA Growth		 -43.65% 44.02% 16.87% 23.09% -16.16% -66.48% 498.87% 33.33% 5.78% -40.94% -58.48%
EBIT Growth		 -47.38% 62.87% -8.77% 31.40% -48.36% -147.27% 789.76% 26.96% 8.78% -63.33% -164.47%
NOPAT Growth		 -46.40% 41.91% -64.98% 240.06% -27.14% -137.48% 960.71% 21.94% -1.28% -67.82% -191.79%
Net Income Growth		 -45.89% 42.83% -63.32% 211.49% -23.54% -138.54% 913.74% 16.17% 10.41% -69.05% -187.41%
EPS Growth		 -45.45% 44.44% -65.38% 222.22% -24.14% -140.91% 855.56% 14.71% 1.28% -69.62% -187.50%
Operating Cash Flow Growth		 -31.80% 22.58% 68.89% 51.34% -176.69% 138.64% 233.81% -112.81% 1,266.52% -76.42% 91.44%
Free Cash Flow Firm Growth		 -32.13% 21.22% -710.45% 87.24% 41.33% 77.33% -2,991.88% 70.34% 507.66% -356.52% 102.80%
Invested Capital Growth		 -9.43% -8.75% 246.35% 18.71% 10.44% -1.20% 45.79% 20.81% -6.56% 56.35% -3.44%
Revenue Q/Q Growth		 -4.71% 6.16% 15.79% -1.19% -7.36% 2.40% 9.67% 9.41% -3.54% 7.15% -3.22%
EBITDA Q/Q Growth		 -29.06% 56.55% -50.84% 141.66% 32.02% -35.47% 9.01% 32.61% -11.97% 0.75% 7.74%
EBIT Q/Q Growth		 -33.99% 72.42% -61.47% 390.09% 78.48% -854.26% 10.10% 52.99% -16.63% 7.96% -26.17%
NOPAT Q/Q Growth		 -33.63% 59.44% -85.70% 495.95% 176.14% -788.32% 11.29% 51.19% -20.69% 32.70% -27.48%
Net Income Q/Q Growth		 -33.23% 57.28% -85.10% 512.08% 188.09% -528.23% 10.08% 53.72% -16.07% 1.72% -11.52%
EPS Q/Q Growth		 -30.77% 44.44% -85.48% 583.33% 266.67% -550.00% 11.48% 52.94% -19.39% 9.09% -16.67%
Operating Cash Flow Q/Q Growth		 -44.13% 84.83% -6.37% 18.15% -55.85% 3.90% 20.86% -47.92% 17.50% -35.41% -33.04%
Free Cash Flow Firm Q/Q Growth		 -46.20% 123.54% -39.44% 62.12% -159.31% 92.40% -186.00% 87.91% 27.58% 6.95% -88.52%
Invested Capital Q/Q Growth		 -4.62% -13.67% -2.84% -3.78% 11.67% -2.12% 68.83% 4.37% -3.27% -3.82% 2.96%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 48.08% 50.66% 51.93% 50.15% 48.18% 44.78% 48.57% 45.74% 46.21% 42.41% 42.98%
EBITDA Margin		 8.58% 11.95% 8.41% 8.80% 9.56% 3.61% 13.71% 13.28% 13.31% 7.42% 3.54%
Operating Margin		 6.59% 10.31% 5.41% 6.59% 4.20% -2.26% 9.97% 9.18% 8.47% 2.60% -3.27%
EBIT Margin		 6.64% 10.46% 5.75% 6.42% 4.29% -2.29% 10.00% 9.23% 9.51% 3.29% -2.44%
Profit (Net Income) Margin		 4.79% 6.61% 1.46% 3.87% 3.83% -1.66% 8.58% 7.24% 7.58% 2.21% -2.22%
Tax Burden Percent		 72.05% 63.18% 25.40% 60.22% 89.17% 72.71% 86.68% 83.40% 84.56% 83.70% 78.43%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 98.95% 94.11% 94.21% 80.33% 116.23%
Effective Tax Rate		 27.95% 36.82% 74.60% 39.78% 10.83% 0.00% 13.32% 16.60% 15.44% 16.30% 0.00%
Return on Invested Capital (ROIC)		 17.79% 27.77% 4.57% 9.15% 5.84% -2.10% 14.77% 13.76% 12.83% 3.33% -2.55%
ROIC Less NNEP Spread (ROIC-NNEP)		 17.72% 27.63% 4.25% 10.33% 4.84% -1.06% 46.24% 4.36% 8.48% 2.94% 13.00%
Return on Net Nonoperating Assets (RNNOA)		 -12.49% -20.56% -2.04% -1.76% -0.54% 0.10% -0.15% 0.37% -1.24% -0.39% 0.07%
Return on Equity (ROE)		 5.30% 7.21% 2.53% 7.39% 5.29% -2.00% 14.63% 14.13% 11.59% 2.95% -2.48%
Cash Return on Invested Capital (CROIC)		 27.68% 36.92% -105.82% -7.96% -4.09% -0.89% -22.48% -5.09% 19.61% -40.63% 0.95%
Operating Return on Assets (OROA)		 6.56% 10.16% 7.29% 7.78% 4.10% -2.02% 10.23% 10.08% 9.58% 3.00% -1.83%
Return on Assets (ROA)		 4.73% 6.42% 1.85% 4.68% 3.66% -1.47% 8.78% 7.91% 7.63% 2.01% -1.66%
Return on Common Equity (ROCE)		 5.30% 7.21% 2.53% 7.39% 5.29% -2.00% 14.63% 14.13% 11.59% 2.95% -2.48%
Return on Equity Simple (ROE_SIMPLE)		 5.18% 7.03% 2.48% 7.08% 5.18% -2.00% 13.28% 13.03% 9.70% 2.90% 0.00%
Net Operating Profit after Tax (NOPAT)		 1.85 2.62 0.92 3.12 2.27 -0.85 7.33 8.94 8.83 2.84 -2.61
NOPAT Margin		 4.75% 6.51% 1.37% 3.97% 3.75% -1.58% 8.64% 7.65% 7.16% 2.17% -2.29%
Net Nonoperating Expense Percent (NNEP)		 0.06% 0.14% 0.31% -1.18% 1.00% -1.04% -31.47% 9.40% 4.36% 0.39% -15.56%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - - 7.89% 2.29% -2.20%
Cost of Revenue to Revenue		 51.92% 49.34% 48.07% 49.85% 51.82% 55.22% 51.43% 54.26% 53.79% 57.59% 57.02%
SG&A Expenses to Revenue		 31.37% 31.25% 29.64% 28.53% 35.40% 35.24% 31.75% 30.12% 31.57% 33.27% 34.27%
R&D to Revenue		 10.12% 9.10% 6.44% 6.25% 8.18% 9.42% 6.52% 6.44% 6.18% 6.54% 8.29%
Operating Expenses to Revenue		 41.49% 40.35% 46.52% 43.56% 43.98% 47.04% 38.60% 36.57% 37.74% 39.81% 46.25%
Earnings before Interest and Taxes (EBIT)		 2.58 4.21 3.84 5.04 2.60 -1.23 8.49 11 12 4.30 -2.77
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 3.34 4.81 5.62 6.91 5.80 1.94 12 16 16 9.69 4.02
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.24 1.26 2.29 1.50 1.39 1.53 2.52 1.75 1.72 1.07 0.90
Price to Tangible Book Value (P/TBV)		 1.35 1.36 9.45 4.52 3.58 3.68 11.78 4.58 2.85 2.49 2.01
Price to Revenue (P/Rev)		 1.15 1.19 1.35 0.82 1.03 1.27 1.63 0.97 1.34 0.81 0.82
Price to Earnings (P/E)		 24.01 17.96 92.38 21.17 26.89 0.00 18.99 13.42 17.70 36.77 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 4.17% 5.57% 1.08% 4.72% 3.72% 0.00% 5.27% 7.45% 5.65% 2.72% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 1.92 2.12 2.63 1.58 1.43 1.59 2.42 1.68 2.04 1.06 0.90
Enterprise Value to Revenue (EV/Rev)		 0.49 0.48 1.23 0.75 0.97 1.19 1.68 1.03 1.10 0.85 0.79
Enterprise Value to EBITDA (EV/EBITDA)		 5.68 3.98 14.62 8.48 10.11 32.99 12.24 7.72 8.27 11.40 22.38
Enterprise Value to EBIT (EV/EBIT)		 7.34 4.55 21.40 11.62 22.51 0.00 16.78 11.11 11.57 25.70 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 10.28 7.30 89.54 18.79 25.79 0.00 19.43 13.40 15.37 38.91 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 5.42 4.46 11.34 5.35 0.00 19.74 13.14 0.00 8.37 28.92 12.31
Enterprise Value to Free Cash Flow (EV/FCFF)		 6.60 5.49 0.00 0.00 0.00 0.00 0.00 0.00 10.06 0.00 92.80
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.14 0.28 0.08 0.14 0.46 0.32 0.16 0.24 0.14
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.08 0.14 0.39 0.26 0.12 0.17 0.09
Financial Leverage		 -0.70 -0.74 -0.48 -0.17 -0.11 -0.09 0.00 0.09 -0.15 -0.13 0.01
Leverage Ratio		 1.12 1.12 1.37 1.58 1.45 1.36 1.67 1.79 1.52 1.46 1.49
Compound Leverage Factor		 1.12 1.12 1.37 1.58 1.45 1.36 1.65 1.68 1.43 1.18 1.73
Debt to Total Capital		 0.00% 0.00% 12.00% 22.10% 7.80% 11.91% 31.62% 24.30% 13.90% 19.42% 12.55%
Short-Term Debt to Total Capital		 0.00% 0.00% 12.00% 22.10% 0.00% 0.00% 5.11% 4.78% 3.67% 6.05% 5.12%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 7.80% 11.91% 26.50% 19.52% 10.23% 13.37% 7.43%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 88.00% 77.90% 92.20% 88.09% 68.38% 75.70% 86.10% 80.58% 87.45%
Debt to EBITDA		 0.00 0.00 0.95 1.76 0.65 3.11 2.18 1.34 0.95 2.48 3.70
Net Debt to EBITDA		 0.00 0.00 -1.41 -0.82 -0.66 -2.18 0.36 0.40 -1.81 0.44 -0.79
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.65 3.11 1.83 1.08 0.70 1.71 2.19
Debt to NOPAT		 0.00 0.00 5.84 3.90 1.67 -7.10 3.46 2.33 1.76 8.47 -5.70
Net Debt to NOPAT		 0.00 0.00 -8.65 -1.83 -1.68 4.96 0.57 0.70 -3.37 1.49 1.22
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 1.67 -7.10 2.90 1.87 1.30 5.83 -3.38
Altman Z-Score		 9.01 8.23 4.20 3.58 4.43 3.91 3.42 3.67 4.76 2.95 2.60
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 8.44 7.52 2.15 1.66 2.98 3.04 2.08 2.24 3.53 2.47 2.20
Quick Ratio		 7.42 6.72 1.77 1.33 2.02 2.11 1.50 1.29 2.61 1.54 1.12
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 2.87 3.48 -21 -2.71 -1.59 -0.36 -11 -3.31 13 -35 0.97
Operating Cash Flow to CapEx		 583.97% 1,264.90% 1,021.44% 495.48% -1,355.65% 501.23% 1,090.74% -101.76% 1,255.07% 288.60% 448.22%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 -125.38 -5.21 19.87 -40.91 2.16
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 121.82 -2.19 23.86 4.52 16.26
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 110.65 -4.34 21.96 2.95 12.63
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.99 0.97 1.27 1.21 0.96 0.88 1.02 1.09 1.01 0.91 0.75
Accounts Receivable Turnover		 8.25 8.23 7.62 6.91 6.11 6.07 6.80 6.19 6.26 5.48 4.11
Inventory Turnover		 5.54 5.52 7.43 6.82 4.59 4.06 4.29 3.58 3.11 3.21 2.22
Fixed Asset Turnover		 32.68 39.13 53.76 36.90 23.62 22.57 33.70 40.15 39.01 34.18 24.65
Accounts Payable Turnover		 18.84 17.43 18.89 20.51 16.67 13.48 13.02 10.86 10.27 11.14 3.36
Days Sales Outstanding (DSO)		 44.25 44.33 47.93 52.80 59.75 60.12 53.69 58.97 58.30 66.57 88.80
Days Inventory Outstanding (DIO)		 65.88 66.16 49.12 53.53 79.55 90.01 85.03 102.00 117.37 113.78 164.26
Days Payable Outstanding (DPO)		 19.37 20.94 19.32 17.80 21.89 27.07 28.03 33.61 35.54 32.76 108.77
Cash Conversion Cycle (CCC)		 90.76 89.56 77.72 88.53 117.40 123.07 110.69 127.36 140.13 147.59 144.29
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 9.87 9.00 31 37 41 40 59 71 66 104 100
Invested Capital Turnover		 3.75 4.26 3.33 2.30 1.56 1.32 1.71 1.80 1.79 1.53 1.11
Increase / (Decrease) in Invested Capital		 -1.03 -0.86 22 5.83 3.87 -0.49 18 12 -4.67 37 -3.58
Enterprise Value (EV)		 19 19 82 59 59 64 142 120 136 111 90
Market Capitalization		 45 48 90 64 62 68 138 114 165 106 93
Book Value per Share		 $3.40 $3.64 $3.77 $4.09 $4.27 $4.25 $5.04 $5.89 $7.92 $8.06 $8.30
Tangible Book Value per Share		 $3.14 $3.39 $0.92 $1.36 $1.66 $1.77 $1.08 $2.25 $4.77 $3.45 $3.72
Total Capital		 36 38 45 55 49 51 80 86 112 124 118
Total Debt		 0.00 0.00 5.36 12 3.79 6.05 25 21 16 24 15
Total Long-Term Debt		 0.00 0.00 0.00 0.00 3.79 6.05 21 17 11 17 8.81
Net Debt		 -26 -29 -7.94 -5.69 -3.82 -4.23 4.15 6.27 -30 4.22 -3.19
Capital Expenditures (CapEx)		 0.60 0.34 0.71 2.21 0.62 0.65 0.99 1.37 1.29 1.32 1.63
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 4.50 4.34 8.65 8.51 8.92 7.83 9.91 23 20 35 31
Debt-free Net Working Capital (DFNWC)		 30 33 22 26 17 18 31 37 66 54 49
Net Working Capital (NWC)		 30 33 17 14 17 18 27 33 61 47 43
Net Nonoperating Expense (NNE)		 -0.02 -0.04 -0.06 0.08 -0.05 0.04 0.05 0.48 -0.51 -0.05 -0.08
Net Nonoperating Obligations (NNO)		 -26 -29 -8.11 -5.87 -3.96 -4.37 4.05 6.17 -30 4.12 -3.19
Total Depreciation and Amortization (D&A)		 0.75 0.60 1.78 1.87 3.19 3.17 3.15 4.73 4.68 5.39 6.80
Debt-free, Cash-free Net Working Capital to Revenue		 11.56% 10.79% 12.94% 10.83% 14.71% 14.55% 11.68% 19.44% 16.48% 26.42% 27.14%
Debt-free Net Working Capital to Revenue		 77.67% 81.91% 32.84% 33.57% 27.26% 33.64% 36.65% 31.91% 53.19% 41.59% 43.00%
Net Working Capital to Revenue		 77.67% 81.91% 24.82% 18.08% 27.26% 33.64% 31.82% 28.40% 49.86% 35.86% 37.67%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.18 $0.26 $0.09 $0.29 $0.22 ($0.09) $0.70 $0.00 $0.82 $0.24 ($0.21)
Adjusted Weighted Average Basic Shares Outstanding		 10.47M 10.31M 10.28M 10.35M 10.37M 10.26M 10.46M 0.00 11.46M 12.15M 12.20M
Adjusted Diluted Earnings per Share		 $0.18 $0.26 $0.09 $0.29 $0.22 ($0.09) $0.68 $0.00 $0.79 $0.24 ($0.21)
Adjusted Weighted Average Diluted Shares Outstanding		 10.49M 10.33M 10.34M 10.38M 10.39M 10.26M 10.73M 0.00 11.78M 12.24M 12.20M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 10.50M 10.40M 10.47M 10.57M 10.43M 10.70M 10.96M 0.00 12.16M 12.37M 12.50M
Normalized Net Operating Profit after Tax (NOPAT)		 1.85 2.62 2.53 3.12 2.49 0.05 7.33 8.94 8.83 2.84 -2.01
Normalized NOPAT Margin		 4.75% 6.51% 3.78% 3.97% 4.10% 0.09% 8.64% 7.65% 7.16% 2.17% -1.77%
Pre Tax Income Margin		 6.64% 10.46% 5.75% 6.42% 4.29% -2.29% 9.90% 8.68% 8.96% 2.64% -2.83%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 95.40 16.98 17.27 5.08 -6.16
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 82.39 14.08 13.00 3.36 -5.79
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 84.24 14.83 15.37 3.52 -9.79
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 71.22 11.93 11.10 1.79 -9.42
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 8.33% 36.79% 6.36% 0.00% 49.18% -8.27% 0.00% 0.00% 0.00% 36.04% 0.00%

Quarterly Metrics And Ratios for inTEST

This table displays calculated financial ratios and metrics derived from inTEST's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding		 24,326,010.00 12,164,698.00 12,489,642.00 12,516,280.00 - 12,373,276.00 12,492,809.00 12,477,676.00 12,483,433.00 12,495,544.00 12,564,657.00
DEI Adjusted Shares Outstanding		 24,326,010.00 12,164,698.00 12,489,642.00 12,516,280.00 - 12,373,276.00 12,492,809.00 12,477,676.00 12,483,433.00 12,495,544.00 12,564,657.00
DEI Earnings Per Adjusted Shares Outstanding		 0.06 0.05 0.02 0.04 - -0.19 -0.04 -0.08 0.10 0.06 0.04
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -13.95% -6.56% 4.40% -2.16% 31.27% -10.69% -17.24% -13.33% -10.33% 27.21% 25.54%
EBITDA Growth		 -43.60% -53.51% -56.03% -39.57% 2.49% -140.56% -46.89% -76.70% 9.77% 401.12% 75.57%
EBIT Growth		 -57.65% -74.08% -84.50% -72.74% 18.44% -384.47% -184.52% -243.65% -28.24% 140.08% 167.24%
NOPAT Growth		 -69.43% -85.83% -90.59% -79.47% 68.40% -587.30% -348.54% -297.11% -33.62% 138.20% 206.49%
Net Income Growth		 -55.15% -76.50% -91.77% -78.26% 3.37% -451.81% -318.70% -289.49% -17.35% 133.88% 194.23%
EPS Growth		 -63.33% -80.00% -91.67% -78.95% 18.18% -480.00% -300.00% -300.00% -23.08% 131.58% 200.00%
Operating Cash Flow Growth		 106.35% -16.47% -278.10% -31.23% -44.75% 166.75% 86.48% -17.86% -139.51% -159.89% 1,018.46%
Free Cash Flow Firm Growth		 164.13% -297.10% -1,112.23% -2,679.15% -727.10% 88.55% 120.86% 124.84% 113.21% -100.01% -46.13%
Invested Capital Growth		 -6.56% 34.85% 51.83% 57.25% 56.35% 0.83% -7.66% -9.72% -3.44% 6.56% -3.45%
Revenue Q/Q Growth		 -9.88% 6.96% 13.97% -10.94% 20.91% -27.23% 5.61% -6.73% 25.10% 3.24% 4.21%
EBITDA Q/Q Growth		 -28.82% -23.48% -6.16% 18.23% 20.73% -130.28% 222.88% -48.14% 468.83% -16.93% -28.35%
EBIT Q/Q Growth		 -40.54% -46.07% -40.78% 43.53% 158.38% -229.52% 82.40% -143.97% 229.06% -27.65% -70.48%
NOPAT Q/Q Growth		 -50.07% -59.84% -36.91% 62.27% 309.57% -216.22% 67.82% -28.69% 237.93% -33.11% -10.31%
Net Income Q/Q Growth		 -36.10% -54.50% -65.26% 115.22% 203.84% -254.85% 78.40% -86.48% 232.52% -36.52% -39.92%
EPS Q/Q Growth		 -42.11% -54.55% -60.00% 100.00% 225.00% -246.15% 78.95% -100.00% 225.00% -40.00% -33.33%
Operating Cash Flow Q/Q Growth		 -24.23% -55.68% -345.30% 183.48% -39.12% 113.95% -112.43% 607.27% -129.28% -224.36% 290.62%
Free Cash Flow Firm Q/Q Growth		 277.49% -532.70% -51.57% -4.17% 8.22% 92.12% 376.28% 24.02% -51.06% -219.28% 174.41%
Invested Capital Q/Q Growth		 -3.27% 45.90% 13.64% -1.95% -3.82% -6.00% 4.07% -4.14% 2.96% 3.73% -5.70%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 44.65% 43.84% 40.59% 46.29% 39.72% 41.51% 42.56% 41.90% 45.39% 45.47% 40.49%
EBITDA Margin		 10.35% 7.41% 6.10% 8.10% 8.08% -3.36% 3.91% 2.18% 9.90% 7.96% 5.47%
Operating Margin		 3.98% 1.65% 0.99% 1.61% 5.68% -10.82% -3.30% -4.55% 3.89% 2.82% 1.03%
EBIT Margin		 6.16% 3.11% 1.62% 2.60% 5.56% -9.90% -1.65% -4.31% 4.45% 3.12% 0.88%
Profit (Net Income) Margin		 5.22% 2.22% 0.68% 1.64% 4.11% -8.74% -1.79% -3.58% 3.79% 2.33% 1.34%
Tax Burden Percent		 92.91% 84.12% 77.70% 86.99% 83.46% 83.51% 86.28% 76.45% 90.27% 80.76% 190.36%
Interest Burden Percent		 91.10% 84.90% 53.92% 72.21% 88.51% 105.76% 125.65% 108.39% 94.25% 92.43% 79.81%
Effective Tax Rate		 7.09% 15.88% 22.30% 13.01% 16.54% 0.00% 0.00% 0.00% 9.73% 19.24% -90.36%
Return on Invested Capital (ROIC)		 6.62% 1.99% 1.03% 1.93% 7.27% -9.91% -2.65% -3.64% 3.91% 2.73% 2.51%
ROIC Less NNEP Spread (ROIC-NNEP)		 3.03% 48.77% 1.74% 1.12% 9.07% 5.80% 0.31% -9.80% 21.53% 0.78% 6.73%
Return on Net Nonoperating Assets (RNNOA)		 -0.44% 0.31% -0.08% -0.10% -1.19% -0.12% 0.02% -0.16% 0.11% -0.01% -0.33%
Return on Equity (ROE)		 6.18% 2.30% 0.95% 1.83% 6.08% -10.03% -2.63% -3.80% 4.02% 2.72% 2.18%
Cash Return on Invested Capital (CROIC)		 19.61% -22.20% -37.01% -42.09% -40.63% -0.81% 7.15% 8.22% 0.95% -6.23% 5.10%
Operating Return on Assets (OROA)		 6.21% 2.76% 1.35% 2.16% 5.06% -8.21% -1.29% -3.31% 3.34% 2.53% 0.76%
Return on Assets (ROA)		 5.25% 1.97% 0.57% 1.36% 3.74% -7.25% -1.40% -2.74% 2.84% 1.89% 1.15%
Return on Common Equity (ROCE)		 6.18% 2.30% 0.95% 1.83% 6.08% -10.03% -2.63% -3.80% 4.02% 2.72% 2.18%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 7.24% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 1.03 0.41 0.26 0.42 1.74 -2.02 -0.65 -0.84 1.15 0.77 0.69
NOPAT Margin		 3.70% 1.39% 0.77% 1.40% 4.74% -7.57% -2.31% -3.18% 3.51% 2.27% 1.96%
Net Nonoperating Expense Percent (NNEP)		 3.59% -46.78% -0.71% 0.81% -1.80% -15.72% -2.96% 6.16% -17.62% 1.94% -4.22%
Return On Investment Capital (ROIC_SIMPLE)		 0.92% 0.33% 0.20% 0.34% 1.40% -1.68% -0.54% -0.70% 0.97% 0.64% 0.57%
Cost of Revenue to Revenue		 55.35% 56.16% 59.41% 53.71% 60.28% 58.49% 57.44% 58.10% 54.61% 54.53% 59.51%
SG&A Expenses to Revenue		 33.75% 33.55% 30.44% 34.35% 28.12% 38.90% 34.09% 33.90% 30.97% 30.53% 30.31%
R&D to Revenue		 6.92% 6.65% 6.53% 7.21% 5.92% 9.19% 7.98% 8.90% 7.35% 7.64% 7.08%
Operating Expenses to Revenue		 40.67% 42.19% 39.60% 44.68% 34.04% 52.32% 45.86% 46.44% 41.51% 42.65% 39.46%
Earnings before Interest and Taxes (EBIT)		 1.72 0.93 0.55 0.79 2.04 -2.64 -0.46 -1.13 1.46 1.06 0.31
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 2.89 2.21 2.07 2.45 2.96 -0.90 1.10 0.57 3.25 2.70 1.93
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.72 1.62 1.24 0.91 1.07 0.87 0.89 0.96 0.90 1.63 2.12
Price to Tangible Book Value (P/TBV)		 2.85 4.33 3.28 2.28 2.49 2.06 2.09 2.22 2.01 3.52 4.33
Price to Revenue (P/Rev)		 1.34 1.33 1.01 0.75 0.81 0.68 0.75 0.83 0.82 1.41 1.78
Price to Earnings (P/E)		 17.70 22.43 26.69 32.15 36.77 0.00 0.00 0.00 0.00 288.60 145.60
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 5.65% 4.46% 3.75% 3.11% 2.72% 0.00% 0.00% 0.00% 0.00% 0.35% 0.69%
Enterprise Value to Invested Capital (EV/IC)		 2.04 1.64 1.22 0.92 1.06 0.87 0.89 0.95 0.90 1.63 2.23
Enterprise Value to Revenue (EV/Rev)		 1.10 1.31 1.09 0.81 0.85 0.67 0.74 0.79 0.79 1.41 1.71
Enterprise Value to EBITDA (EV/EBITDA)		 8.27 11.46 11.95 10.31 11.40 12.88 16.05 24.93 22.38 22.35 25.90
Enterprise Value to EBIT (EV/EBIT)		 11.57 17.51 22.05 24.89 25.70 115.31 0.00 0.00 0.00 184.68 128.89
Enterprise Value to NOPAT (EV/NOPAT)		 15.37 25.18 35.39 46.31 38.91 5,773.14 0.00 0.00 0.00 1,424.88 137.18
Enterprise Value to Operating Cash Flow (EV/OCF)		 8.37 10.06 17.10 16.76 28.92 11.66 7.71 8.52 12.31 0.00 39.99
Enterprise Value to Free Cash Flow (EV/FCFF)		 10.06 0.00 0.00 0.00 0.00 0.00 11.90 11.01 92.80 0.00 42.89
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.16 0.25 0.31 0.26 0.24 0.21 0.18 0.16 0.14 0.15 0.12
Long-Term Debt to Equity		 0.12 0.16 0.19 0.17 0.17 0.14 0.12 0.10 0.09 0.08 0.07
Financial Leverage		 -0.15 0.01 -0.05 -0.09 -0.13 -0.02 0.05 0.02 0.01 -0.01 -0.05
Leverage Ratio		 1.52 1.63 1.53 1.51 1.46 1.55 1.54 1.52 1.49 1.47 1.42
Compound Leverage Factor		 1.38 1.38 0.83 1.09 1.30 1.64 1.93 1.64 1.41 1.35 1.13
Debt to Total Capital		 13.90% 20.16% 23.85% 20.41% 19.42% 17.05% 15.21% 14.14% 12.55% 12.85% 10.51%
Short-Term Debt to Total Capital		 3.67% 7.74% 9.18% 6.56% 6.05% 5.74% 5.31% 5.51% 5.12% 6.19% 4.44%
Long-Term Debt to Total Capital		 10.23% 12.42% 14.67% 13.85% 13.37% 11.31% 9.90% 8.63% 7.43% 6.66% 6.07%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 86.10% 79.84% 76.15% 79.59% 80.58% 82.95% 84.79% 85.86% 87.45% 87.15% 89.49%
Debt to EBITDA		 0.95 1.81 2.78 2.68 2.48 3.10 3.28 4.49 3.70 2.02 1.50
Net Debt to EBITDA		 -1.81 -0.16 0.96 0.81 0.44 -0.25 -0.15 -1.16 -0.79 -0.04 -1.12
Long-Term Debt to EBITDA		 0.70 1.11 1.71 1.82 1.71 2.06 2.13 2.74 2.19 1.05 0.86
Debt to NOPAT		 1.76 3.97 8.22 12.02 8.47 1,389.39 -21.17 -8.20 -5.70 128.85 7.93
Net Debt to NOPAT		 -3.37 -0.36 2.85 3.63 1.49 -110.48 0.97 2.12 1.22 -2.39 -5.92
Long-Term Debt to NOPAT		 1.30 2.45 5.06 8.16 5.83 921.63 -13.78 -5.01 -3.38 66.78 4.58
Altman Z-Score		 4.52 3.11 2.70 2.46 2.90 2.63 2.71 2.76 2.69 3.79 4.97
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 3.53 2.15 2.24 2.26 2.47 2.39 2.42 2.31 2.20 2.22 2.49
Quick Ratio		 2.61 1.27 1.39 1.29 1.54 1.38 1.38 1.14 1.12 1.20 1.52
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 5.70 -25 -37 -39 -36 -2.82 7.79 9.66 4.73 -5.64 4.20
Operating Cash Flow to CapEx		 1,520.13% 610.29% -1,610.76% 841.39% 1,587.12% 2,417.03% -148.92% 857.49% -191.39% -514.75% 1,560.25%
Free Cash Flow to Firm to Interest Expense		 37.22 -176.03 -147.64 -177.69 -152.63 -18.56 65.49 101.74 56.31 -70.52 66.64
Operating Cash Flow to Interest Expense		 30.60 14.82 -20.12 19.40 11.06 36.41 -5.78 36.74 -12.17 -41.44 100.30
Operating Cash Flow Less CapEx to Interest Expense		 28.59 12.39 -21.37 17.10 10.36 34.91 -9.66 32.45 -18.52 -49.49 93.87
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.01 0.89 0.84 0.83 0.91 0.83 0.78 0.77 0.75 0.81 0.86
Accounts Receivable Turnover		 6.26 5.53 4.75 4.97 5.48 5.79 4.55 4.78 4.11 4.72 5.11
Inventory Turnover		 3.11 2.37 2.67 2.55 3.21 2.51 2.49 2.31 2.22 2.34 2.62
Fixed Asset Turnover		 39.01 30.39 31.66 31.62 34.18 27.72 26.43 25.31 24.65 25.78 26.75
Accounts Payable Turnover		 10.27 6.90 9.83 8.32 11.14 5.14 5.58 5.21 3.36 3.74 4.04
Days Sales Outstanding (DSO)		 58.30 66.02 76.86 73.42 66.57 63.03 80.14 76.43 88.80 77.37 71.44
Days Inventory Outstanding (DIO)		 117.37 153.87 136.82 143.09 113.78 145.16 146.32 157.70 164.26 156.28 139.48
Days Payable Outstanding (DPO)		 35.54 52.92 37.14 43.89 32.76 71.06 65.42 70.06 108.77 97.52 90.38
Cash Conversion Cycle (CCC)		 140.13 166.98 176.54 172.62 147.59 137.13 161.04 164.07 144.29 136.13 120.54
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 66 97 110 108 104 98 102 98 100 104 98
Invested Capital Turnover		 1.79 1.44 1.34 1.38 1.53 1.31 1.15 1.14 1.11 1.20 1.28
Increase / (Decrease) in Invested Capital		 -4.67 25 38 39 37 0.80 -8.44 -11 -3.58 6.41 -3.51
Enterprise Value (EV)		 136 159 134 99 111 85 90 93 90 170 219
Market Capitalization		 165 161 123 91 106 86 91 97 93 171 228
Book Value per Share		 $7.92 $8.16 $7.97 $8.02 $8.06 $8.03 $8.21 $8.16 $8.30 $8.36 $8.57
Tangible Book Value per Share		 $4.77 $3.06 $3.01 $3.20 $3.45 $3.40 $3.48 $3.52 $3.72 $3.88 $4.20
Total Capital		 112 124 131 126 124 120 121 119 118 120 120
Total Debt		 16 25 31 26 24 20 18 17 15 15 13
Total Long-Term Debt		 11 15 19 17 17 14 12 10 8.81 7.98 7.30
Net Debt		 -30 -2.25 11 7.77 4.22 -1.62 -0.84 -4.33 -3.19 -0.29 -9.45
Capital Expenditures (CapEx)		 0.31 0.34 0.32 0.51 0.16 0.23 0.46 0.41 0.53 0.64 0.41
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 20 28 37 36 35 28 31 28 31 36 31
Debt-free Net Working Capital (DFNWC)		 66 55 57 54 54 50 50 49 49 51 53
Net Working Capital (NWC)		 61 46 45 45 47 44 44 43 43 44 48
Net Nonoperating Expense (NNE)		 -0.42 -0.25 0.03 -0.07 0.23 0.31 -0.15 0.10 -0.09 -0.02 0.22
Net Nonoperating Obligations (NNO)		 -30 -2.35 11 7.67 4.12 -1.62 -0.84 -4.33 -3.19 -0.29 -9.45
Total Depreciation and Amortization (D&A)		 1.17 1.28 1.52 1.66 0.92 1.74 1.57 1.70 1.79 1.64 1.62
Debt-free, Cash-free Net Working Capital to Revenue		 16.48% 23.13% 29.96% 29.15% 26.42% 22.29% 25.54% 23.88% 27.14% 29.34% 24.18%
Debt-free Net Working Capital to Revenue		 53.19% 45.68% 46.57% 43.89% 41.59% 39.58% 41.36% 41.81% 43.00% 42.30% 41.41%
Net Working Capital to Revenue		 49.86% 37.73% 36.80% 37.11% 35.86% 34.19% 36.08% 36.26% 37.67% 36.17% 37.24%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.12 $0.06 $0.02 $0.04 $0.12 ($0.19) ($0.04) ($0.08) $0.10 $0.06 $0.04
Adjusted Weighted Average Basic Shares Outstanding		 11.46M 12.03M 12.23M 12.19M 12.15M 12.18M 12.22M 12.21M 12.20M 12.25M 12.31M
Adjusted Diluted Earnings per Share		 $0.11 $0.05 $0.02 $0.04 $0.13 ($0.19) ($0.04) ($0.08) $0.10 $0.06 $0.04
Adjusted Weighted Average Diluted Shares Outstanding		 11.78M 12.16M 12.33M 12.25M 12.24M 12.18M 12.22M 12.21M 12.20M 12.42M 12.58M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 12.16M 12.49M 12.52M 12.37M 12.37M 12.49M 12.48M 12.48M 12.50M 12.56M 12.83M
Normalized Net Operating Profit after Tax (NOPAT)		 1.03 0.41 0.26 0.42 1.74 -1.80 -0.50 -0.75 1.34 1.37 0.28
Normalized NOPAT Margin		 3.70% 1.39% 0.77% 1.40% 4.74% -6.75% -1.77% -2.87% 4.07% 4.05% 0.78%
Pre Tax Income Margin		 5.62% 2.64% 0.87% 1.88% 4.92% -10.47% -2.07% -4.68% 4.20% 2.88% 0.71%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 11.24 6.62 2.17 3.60 8.70 -17.35 -3.90 -11.92 17.39 13.21 4.95
NOPAT to Interest Expense		 6.73 2.96 1.03 1.93 7.42 -13.27 -5.45 -8.79 13.71 9.63 10.97
EBIT Less CapEx to Interest Expense		 9.22 4.19 0.92 1.29 8.00 -18.86 -7.78 -16.20 11.04 5.16 -1.48
NOPAT Less CapEx to Interest Expense		 4.72 0.53 -0.22 -0.37 6.72 -14.77 -9.34 -13.07 7.36 1.58 4.54
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 36.66% 36.04% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

inTEST (NYSE: INTT) showed a meaningful deterioration in profitability and cash generation in Q1 2026 compared with the prior year and even versus recent 2025 quarters. Revenue held up reasonably well, but operating costs, working-capital pressure, and debt obligations weighed on results. The balance sheet still has a solid equity base, but liquidity is not as comfortable as the cash balance alone may suggest.

  • Revenue improved year over year in Q1 2026, rising to $33.9 million from $29.8 million in Q1 2025, showing the business is still generating sales growth.
  • Gross profit increased to $15.4 million from $11.1 million a year earlier, indicating better top-line scale and a higher gross-dollar base.
  • Other income helped offset core weakness, with net other income/expense contributing modestly to pre-tax income in Q1 2026.
  • Interest-bearing debt appears to have come down over time versus early 2025 levels, suggesting some balance-sheet repair on the financing side.
  • Revenue has been fairly consistent across the last four quarters, generally staying in the high-$20 million to mid-$30 million range, so the business has not seen a collapse in demand.
  • Shares outstanding were broadly stable year over year, so earnings changes were driven more by operating performance than by major dilution.
  • Cash and equivalents totaled $12.9 million at Q1 2026, but restricted cash and sizable current liabilities reduce the comfort level of that cash position.
  • Operating income fell sharply in Q1 2026 to just $954,000 from $4.5 million in Q1 2025, showing a significant margin squeeze.
  • Net income dropped dramatically year over year to $789,000 in Q1 2026 from $3.24 million in Q1 2025, and from $1.24 million in Q4 2025.
  • Operating cash flow was negative in Q1 2026 at $(3.3) million, a reversal from positive operating cash flow in Q1 2025 and Q3 2025.
  • Working capital was a major drag, with changes in operating assets and liabilities consuming $6.4 million in Q1 2026.
  • Margins weakened materially: Q1 2026 operating margin was about 2.8%, far below the much healthier levels seen in parts of 2024.
  • Restructuring charges remain part of the cost structure, adding to the impression that management is still dealing with a turnaround or efficiency effort.
  • Current liabilities remain elevated at $35.8 million, including $7.4 million of short-term debt and $18.8 million of accounts payable.
  • Cash declined sequentially from $16.2 million at Q3 2025 to $12.9 million at Q1 2026, reflecting weaker cash conversion.

Longer-term trend: inTEST’s results have been volatile over the last four years. In 2023, the company generally produced stronger profitability and operating cash flow. Through 2024, operating income and cash generation weakened, and 2025 showed a mixed picture with some profitable quarters but uneven cash flow. Q1 2026 is notable because revenue improved, yet profits and operating cash flow deteriorated materially, which suggests the company is struggling to convert sales into bottom-line results.

Bottom line: investors should focus on whether inTEST can restore operating leverage and improve working-capital efficiency. The revenue base appears relatively stable, but the latest quarter shows that earnings quality and cash generation are under pressure. Until operating cash flow improves consistently, the stock likely remains more of a turnaround story than a steady compounder.

08/14/26 05:48 AM ETAI Generated. May Contain Errors.

inTEST Financials - Frequently Asked Questions

According to the most recent income statement we have on file, inTEST's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

inTEST's net income appears to be on an upward trend, with a most recent value of -$2.53 million in 2025, falling from $1.86 million in 2015. The previous period was $2.89 million in 2024. See inTEST's forecast for analyst expectations on what's next for the company.

inTEST's total operating income in 2025 was -$3.73 million, based on the following breakdown:
  • Total Gross Profit: $48.92 million
  • Total Operating Expenses: $52.65 million

Over the last 10 years, inTEST's total revenue changed from $38.89 million in 2015 to $113.83 million in 2025, a change of 192.7%.

inTEST's total liabilities were at $47.69 million at the end of 2025, a 9.2% decrease from 2024, and a 1,074.9% increase since 2015.

In the past 10 years, inTEST's cash and equivalents has ranged from $7.61 million in 2019 to $45.26 million in 2023, and is currently $14.22 million as of their latest financial filing in 2025.

Over the last 10 years, inTEST's book value per share changed from 3.40 in 2015 to 8.30 in 2025, a change of 144.1%.


Related Companies

Financial statements for NYSE:INTT last updated on 8/10/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Elon's Terrifying Warning: America Is "1,000% Going Bankrupt"
The national debt just crossed $39 trillion, and Elon Musk - former head of the Department of Government Effic...
American Hartford Gold | Sponsoredtc pixel
Trump’s New Currency Reset
Trump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...
Porter & Company | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Man who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown”
In 2016, major election models gave Hillary Clinton a 99% chance of winning - but former CIA and Pentagon advi...
Paradigm Press | Sponsoredtc pixel
The Starlink of Energy
A portable energy unit - already used by the U.S. Navy for decades - is now drawing serious attention from Big...
Monument Traders Alliance | Sponsoredtc pixel
Three oil giants buried the same discovery for 50 years
In 1976, Chevron tapped an energy source with no fuel costs, no carbon, and no supply chain - then killed the ...
Behind the Markets | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel